120 related articles for article (PubMed ID: 37533234)
1. Knowledge assessment of a donor adverse reaction severity grading tool by the National Blood Donor Vigilance Programme of India.
Bisht A; Arora S; Patidar G; Marwaha N
Vox Sang; 2023 Sep; 118(9):721-729. PubMed ID: 37533234
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of donor adverse reaction severity grading tool: enhancing objective grade assignment to donor adverse events.
Townsend M; Kamel H; Van Buren N; Wiersum-Osselton J; Rosa-Bray M; Gottschall J; Rajbhandary S
Transfusion; 2020 Jun; 60(6):1231-1242. PubMed ID: 32452048
[TBL] [Abstract][Full Text] [Related]
3. The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration.
Mikkelsen C; Paarup HM; Bruun MT; Pedersen LØ; Hasslund S; Larsen R; Aagaard B; Sørensen BS
Vox Sang; 2022 Mar; 117(3):321-327. PubMed ID: 34523137
[TBL] [Abstract][Full Text] [Related]
4. National blood donor vigilance programme of India: Analysis of donor adverse reactions reported during initial 2 years of implementation (2016 and 2017).
Bisht A; Marwaha N; Arora S; Patidar GK; Chhabra R
Asian J Transfus Sci; 2021; 15(1):1-11. PubMed ID: 34349450
[TBL] [Abstract][Full Text] [Related]
5. [Delayed adverse reactions to blood donation: From haemovigilance data to specific studies].
Py JY; Durieux S; Barnoux M; Sapey T
Transfus Clin Biol; 2016 Nov; 23(4):233-239. PubMed ID: 27769684
[TBL] [Abstract][Full Text] [Related]
6. International validation of harmonized definitions for complications of blood donations.
Land KJ; Townsend M; Goldman M; Whitaker BI; Perez GE; Wiersum-Osselton JC
Transfusion; 2018 Nov; 58(11):2589-2595. PubMed ID: 30294786
[TBL] [Abstract][Full Text] [Related]
7. Self-ignored onsite adverse donor reaction among whole blood donors: A single center experience from India.
Rajendran V; Paonam B; Chenna D; Mohan G; Shastry S; Jose P; Kandasamy D
Transfus Clin Biol; 2022 May; 29(2):124-128. PubMed ID: 35031508
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study.
Cho JH; Rajbhandary S; van Buren NL; Fung MK; Al-Ghafry M; Fridey JL; Dy BA; Ziman A; Schreiber GB; Gammon RR; Reik R; Stubbs JR; van Buskirk CM; Kamel H; Townsend MJ; Zeller MP; Gottschall JL
Transfusion; 2021 Sep; 61(9):2668-2676. PubMed ID: 34227689
[TBL] [Abstract][Full Text] [Related]
10. First donor haemovigilance system at a national level in China: Establishment and improvement.
Yang J; Fan D; Xie D; Guo X; Zhu W; He T; Huang X
Vox Sang; 2023 May; 118(5):357-366. PubMed ID: 36896482
[TBL] [Abstract][Full Text] [Related]
11. Donor vigilance data of a blood transfusion service: A multicenter analysis.
Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
[TBL] [Abstract][Full Text] [Related]
12. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
[TBL] [Abstract][Full Text] [Related]
13. Development of standard definitions for surveillance of complications related to blood donation.
Goldman M; Land K; Robillard P; Wiersum-Osselton J
Vox Sang; 2016 Feb; 110(2):185-8. PubMed ID: 26361365
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a tool to score donor vein suitability for blood donation.
Hirani R; O'Donovan J; Knight E; Bell B; Mondy P
Vox Sang; 2019 Aug; 114(6):588-594. PubMed ID: 31273797
[TBL] [Abstract][Full Text] [Related]
15. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic apheresis and non-blood donor related apheresis current practices at various blood centres of healthcare organisations of India: A brief online survey.
Kumawat V; Tripathi PP; Patidar GK
Transfus Med; 2022 Feb; 32(1):45-52. PubMed ID: 34825419
[TBL] [Abstract][Full Text] [Related]
17. Red cell genotyping of rare blood donors: donation behaviour and data visualization.
Anani WQ; Gottschall J; Denomme GA
Vox Sang; 2021 May; 116(5):601-608. PubMed ID: 33400261
[TBL] [Abstract][Full Text] [Related]
18. International haemovigilance: what have we learned and what do we need to do next?
Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
[TBL] [Abstract][Full Text] [Related]
19. Reporting of delayed adverse donor reactions in whole blood donors: Just the tip of an iceberg!
Kaur S; Mittal K; Kaur R; Kaur G; Kaur P; Sood T
Transfus Clin Biol; 2022 May; 29(2):141-146. PubMed ID: 34856397
[TBL] [Abstract][Full Text] [Related]
20. AABB validation study of the CDC's National Healthcare Safety Network Hemovigilance Module adverse events definitions protocol.
AuBuchon JP; Fung M; Whitaker B; Malasky J
Transfusion; 2014 Aug; 54(8):2077-83. PubMed ID: 24673261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
